RAC and SEAC adopt their first opinions on restriction proposals
17 March, 2011The RAC has adopted two proposals, to restrict DMFu in articles and to restrict lead in jewellery, which are supported by SEAC.
Regulation and harmonisation of genomic data
02 March, 2011 by21 CFR 312.23, 21 CFR 314.50, and 21 CFR 314.81 codify the regulations and guidelines regarding genomic data and applications to the USFDA. This matrix of genomic data submissions requirements and voluntary guides are confusing and difficult to navigate.
IPTA and AusBiotech champion the Intellectual Property Laws Amendments
01 March, 2011IPTA and AusBiotech are urging the Senate Legal and Consitutional Committee to favour the Intellectual Property Laws Amendments instead of patentable subject matter amendments, as they are more comprehensive in terms of Australian patent law.
Efforts to eliminate POPs to be investigated
23 February, 2011An investigation will begin into the international efforts to eliminate or restrict the use of POPs, when CSIRO starts a new atmospheric monitoring program.
Gene patenting report implicates all R&D
16 February, 2011Senate’s gene patenting report fails to offer solutions to Australian healthcare industry.
New independent ethical science and research committee
02 February, 2011Australian taxpayers can be confident the research activities they fund meet the highest ethical and moral standards thanks to the establishment of the government’s Australian Research Integrity Committee.
Independent MPs support boost for R&D
30 November, 2010Businesses will get more support for research and development under legislation passed by the House of Representatives.
New standard for describing marker genes
30 November, 2010An international community of scientists, the Genomic Standards Consortium, has published a new standard for describing marker genes.
Government introduces R&D tax credit
15 October, 2010The Gillard government has introduced the R&D Tax Credit to replace the existing R&D Tax Concession with a claimed to be more certain and more generous R&D incentive to business, particularly SMEs.
Protecting genetic resources
04 May, 2010Comparing the conformity of molecular markers is considered a first step in determining what the 'essential characteristics' of a particular plant variety are.
Win for personalised medicine in US DNA patent case
06 April, 2010In a ruling that will most definitely advance the development of personalised, molecular medicine and the practice of molecular pathology, a US district court has found against gene patenting.
New in vitro diagnostic regulations legislated
04 March, 2010The regulation of in vitro diagnostics in Australia will undergo significant change as pre-market regulatory approval and inclusion on the Australian Register of Therapeutic Goods is required for IVD devices under the new regulatory scheme, which comes into force on 1 July 2010.
Harmonised classification and labelling for three chemical substances
29 January, 2010Indium phosphide, di-tert-butyl peroxide and trixylyl phosphate have been looked at by the Committee for Risk Assessment (RAC) of ECHA (European Chemicals Agency in Helsinki).
15 new substances of very high concern to be added to the Candidate List
08 December, 2009The ECHA Member State Committee has identified 15 new chemical substances for the Candidate List of substances of very high concern which will be added to the Candidate List in January 2010.
Global patent application backlog passes 4.2 million
24 September, 2009The current backlog of patent applications has passed 4.2 million and is growing unsustainably.
